Alan J. Main
2022
In 2022, Alan J. Main earned a total compensation of $1.4M as Executive Vice President, Innovation and Chemical Sciences at Lexicon Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Bonus | $152,457 |
|---|---|
| Option Awards | $580,928 |
| Salary | $426,169 |
| Stock Awards | $246,400 |
| Other | $12,775 |
| Total | $1,418,729 |
Main received $580.9K in option awards, accounting for 41% of the total pay in 2022.
Main also received $152.5K in bonus, $426.2K in salary, $246.4K in stock awards and $12.8K in other compensation.
Rankings
In 2022, Alan J. Main's compensation ranked 2,322nd out of 5,542 executives tracked by ExecPay. In other words, Main earned more than 58.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,322 out of 5,542 | 58th |
Division Manufacturing | 1,258 out of 3,000 | 58th |
Major group Chemicals And Allied Products | 560 out of 1,350 | 59th |
Industry group Drugs | 515 out of 1,253 | 59th |
Industry Pharmaceutical Preparations | 370 out of 907 | 59th |
Source: SEC filing on March 26, 2024.
Main's colleagues
We found four more compensation records of executives who worked with Alan J. Main at Lexicon Pharmaceuticals in 2022.
News
Lexicon Pharmaceuticals CEO Lonnel Coats' 2023 pay slips 1% to $4.1M
March 26, 2024
Lexicon Pharmaceuticals CEO Lonnel Coats' 2021 pay rises 2% to $3.9M
April 8, 2022
Lexicon Pharmaceuticals CEO Lonnel Coats' 2020 pay stays at $3.9M
March 19, 2021
Lexicon Pharmaceuticals CEO Lonnel Coats' 2019 pay jumps 24% to $3.9M
March 13, 2020
Lexicon Pharmaceuticals CEO Lonnel Coats' 2018 pay jumps 41% to $3.1M
March 14, 2019